Legal & General Group’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Sell |
121,980
-6,095
| -5% | -$397K | ﹤0.01% | 1060 |
|
|
2026
Q1 | $6.09M | Sell |
128,075
-43,131
| -25% | -$1.93M | ﹤0.01% | 1404 |
|
|
2025
Q4 | $5.43M | Buy |
171,206
+45,920
| +37% | +$1.43M | ﹤0.01% | 1519 |
|
|
2025
Q3 | $3.53M | Buy |
125,286
+15,000
| +14% | +$454K | ﹤0.01% | 1740 |
|
|
2025
Q2 | $4.06M | Buy |
110,286
+19,915
| +22% | +$688K | ﹤0.01% | 1643 |
|
|
2025
Q1 | $3.55M | Buy |
90,371
+3,203
| +4% | +$144K | ﹤0.01% | 1682 |
|
|
2024
Q4 | $4.05M | Sell |
87,168
-3,900
| -4% | -$176K | ﹤0.01% | 1678 |
|
|
2024
Q3 | $4.11M | Buy |
91,068
+7,734
| +9% | +$368K | ﹤0.01% | 1664 |
|
|
2024
Q2 | $4.11M | Sell |
83,334
-2,078
| -2% | -$84.7K | ﹤0.01% | 1618 |
|
|
2024
Q1 | $2.93M | Sell |
85,412
-14,689
| -15% | -$530K | ﹤0.01% | 1765 |
|
|
2023
Q4 | $3.69M | Sell |
100,101
-24,488
| -20% | -$566K | ﹤0.01% | 1677 |
|
|
2023
Q3 | $2.52M | Sell |
124,589
-23,749
| -16% | -$522K | ﹤0.01% | 1797 |
|
|
2023
Q2 | $3.03M | Buy |
148,338
+25,416
| +21% | +$381K | ﹤0.01% | 1721 |
|
|
2023
Q1 | $1.85M | Buy |
122,922
+22,297
| +22% | +$493K | ﹤0.01% | 1910 |
|
|
2022
Q4 | $2.4M | Buy |
100,625
+13,769
| +16% | +$399K | ﹤0.01% | 1792 |
|
|
2022
Q3 | $3.06M | Sell |
86,856
-29,544
| -25% | -$1.25M | ﹤0.01% | 1634 |
|
|
2022
Q2 | $4.07M | Buy |
116,400
+25,238
| +28% | +$894K | ﹤0.01% | 1519 |
|
|
2022
Q1 | $4.5M | Buy |
91,162
+33,451
| +58% | +$1.85M | ﹤0.01% | 1571 |
|
|
2021
Q4 | $4.47M | Buy |
57,711
+3,468
| +6% | +$356K | ﹤0.01% | 1633 |
|
|
2021
Q3 | $5.8M | Buy |
54,243
+22,992
| +74% | +$2.63M | ﹤0.01% | 1468 |
|
|
2021
Q2 | $4.17M | Buy |
31,251
+1,485
| +5% | +$173K | ﹤0.01% | 1630 |
|
|
2021
Q1 | $3.69M | Buy |
29,766
+21,951
| +281% | +$3.33M | ﹤0.01% | 1721 |
|
|
2020
Q4 | $1.1M | Sell |
7,815
-26
| -0.3% | -$2.88K | ﹤0.01% | 2085 |
|
|
2020
Q3 | $596K | Sell |
7,841
-973
| -11% | -$60.6K | ﹤0.01% | 2170 |
|
|
2020
Q2 | $399K | Buy |
8,814
+3,503
| +66% | +$126K | ﹤0.01% | 2220 |
|
|
2020
Q1 | $163K | Buy |
5,311
+679
| +15% | +$18.3K | ﹤0.01% | 2314 |
|
|
2019
Q4 | $97K | Buy |
4,632
+1,082
| +30% | +$25.3K | ﹤0.01% | 2595 |
|
|
2019
Q3 | $85K | Hold |
3,550
| – | – | ﹤0.01% | 2570 |
|
|
2019
Q2 | $103K | Buy |
3,550
+2,774
| +357% | +$73.4K | ﹤0.01% | 2515 |
|
|
2019
Q1 | $18K | Hold |
776
| – | – | ﹤0.01% | 3131 |
|
|
2018
Q4 | $18K | Buy |
+776
| New | +$17.2K | ﹤0.01% | 3121 |
|
Other funds holding TWST
AIM
EIG
Legal & General Group's TWST Position: Q2 2026 in Review
Legal & General Group reduced its Twist Bioscience (TWST) stake by 4.8% in Q2 2026, selling an estimated $397K and leaving 121,980 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1060.
Legal & General Group first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Legal & General Group held 121,980 shares of Twist Bioscience worth $12.5M as of Q2 2026.
- Legal & General Group sold 6,095 Twist Bioscience shares in Q2 2026, an estimated $397K.
- Twist Bioscience made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1060 holding.
- Legal & General Group first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.